Product Information
AZELASTINE 0.1% (137 MCG) SPRY is a generic product labeled by Apotex Corp., priced at $0.2728 per ML under NDC 60505083305. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Apr 30, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
137 ug/1
Manufacturer
Apotex Corp.NDC
60505083305
Classification
Generic
Dosage Form
SPRAY, METERED
Route
NASAL
Effective Date
9/23/2026
Active Ingredients
AZELASTINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077954FDA Approved
4/30/2009
TE Code
AB
On Market Since
3/1/2010
Pharmacological Classes
Price Statistics
The NADAC for AZELASTINE 0.1% (137 MCG) SPRY has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 79.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2728 per ML |
|---|---|
| All-time high | $1.2993 (Dec 11, 2013) |
| All-time low | $0.2304 (Nov 20, 2024) |
| 52-week high | $0.2900 |
| 52-week low | $0.2728 |
| Median price | $0.3400 |
| Average price | $0.4891 |
| Largest weekly change | -18.8% (Nov 20, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the azelastine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Apotex Corp. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
azelastine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AZELASTINE 0.1% (137 MCG) SPRY?
The current National Average Drug Acquisition Cost (NADAC) for AZELASTINE 0.1% (137 MCG) SPRY, manufactured by Apotex Corp., is $0.2728 per ML (NDC 60505083305), effective Sep 30, 2026.
How has the price of AZELASTINE 0.1% (137 MCG) SPRY changed over time?
Over the history we have for it, the NADAC for AZELASTINE 0.1% (137 MCG) SPRY has declined 79.0%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for AZELASTINE 0.1% (137 MCG) SPRY?
Since Nov 28, 2013, the NADAC for AZELASTINE 0.1% (137 MCG) SPRY has ranged from a low of $0.2304 (Nov 20, 2024) to a high of $1.2993 (Dec 11, 2013), with a median of $0.3400 per ML.
Are there cheaper alternatives to AZELASTINE 0.1% (137 MCG) SPRY?
No other NADAC-published product currently shares the active ingredient and strength of AZELASTINE 0.1% (137 MCG) SPRY in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AZELASTINE 0.1% (137 MCG) SPRY?
AZELASTINE 0.1% (137 MCG) SPRY (NDC 60505083305) is labeled by Apotex Corp., and CMS classifies it as a generic product.